AC
Avery W Catlin
Director

Avery W Catlin insider trades: Provention Bio (PRVB) stock buys and sales

Director, Provention Bio Last trade Dec 26, 2018 53 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2006
4
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Avery reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 26, 2018PRVB↑ Buy$19K
Nov 9, 2018PRVB↑ Buy$32K
May 11, 2017CRBP↑ Buy$31K
Nov 22, 2016CRBP↑ Buy$15K
Nov 23, 2015CLDX↓ Sell$450K
Aug 18, 2015CRBP↑ Buy$16K
Aug 17, 2015CRBP↑ Buy$23K
Jun 15, 2015CLDX↓ Sell$615K
Jun 9, 2015CRBP↑ Buy$62K
Dec 6, 2013CLDX↓ Sell$4.5M
Aug 9, 2011CLDX↑ Buy$5K
Sep 8, 2010CLDX↑ Buy$7K
Nov 30, 2009CLDX↑ Buy$4K
Aug 16, 2006AVAN↑ Buy$7K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Avery W Catlin's insider trades

Avery W Catlin is a director at Provention Bio (PRVB). Since Aug 16, 2006, Avery has reported 11 open-market purchases worth $219K and 3 sales worth $5.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (27 filings), option exercises (9 filings), other transactions (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.